BENDHEIM JACK (President and CEO) sold 12.8% of their position (5.75K shares) of PHIBRO ANIMAL HEALTH CORP on the open market
Open‑market sale worth $235.4K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 12/15/2025ACC: 0001104659-25-121213
DirectorOfficer10% Owner· President and CEO
Since Jul 2018
-5.75K
Net shares
Net seller
$235.4K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
5.75K disposed
Non-Derivative Transactions2
Class A Common Stock
Indirect
Shares
−2.76K
Price / share
$40.61
Trade value
$111.96K
% of position
6.1%
12/11/2025
44.95K→42.20K
Class A Common Stock
Indirect
Shares
−3K
Price / share
$41.22
Trade value
$123.44K
% of position
7.1%
12/11/2025
42.20K→39.20K
Total
Net shares
−5.75K
Net value
-$235.40K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Indirect | 12/11/2025 | S · Sale | −2.76K | $40.61 | $111.96K | 6.1% | 44.95K | 42.20K |
| Class A Common Stock Indirect | 12/11/2025 | S · Sale | −3K | $41.22 | $123.44K | 7.1% | 42.20K | 39.20K |
| Total | −5.75K | -$235.40K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Class A Common Stock
DirectShares owned16.84K
Total
16.84K direct16.84K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Class A Common Stock | 16.84K | Direct |
| Total | 16.84K | 16.84K direct |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported